Please note that the Terms of Reference are currently being revised.
Information on this website should be read in conjunction with the University Policy for Clinical Research.
University Research Committee
The Committee shall meet on a twice-yearly basis and conduct urgent business electronically, or by arrangement of additional meetings, in the interim.
Definitions taken from glossary of the Medical Research Council Experimental Medicine Toolkit.
An individual, company, institution or organisation which takes responsibility for the initiation, management and/or financing of a clinical trial. (from the EU Directive 2001/20/EC).
A clinical trial is any prospective evaluation of a health care intervention, which involves the administration of a treatment or type of management, including diagnosis or the provision of lifestyle (e.g. dietary) advice.
Clinical Trial of an Investigational Medicinal Product, i.e. a clinical trial that is within the scope of the UK Medicines for Human Use (Clinical Trials) Regulations 2004.
An Investigational Medicinal Product is a pharmaceutical form of an active substance or placebo being tested or used as a reference in a CTIMP. This includes products already with a marketing authorisation: when used or assembled (formulated or packaged) in a way different from the authorised form, when used for an unauthorised indication, or when used to gain further information about the authorised form.
Issue date: September 2010, updated September 2021
|2||Dean of the Hull York Medical School (HYMS), or their representative|
|3||The Director of the York Clinical Trials Unit|
|4||The Director of the Research and Enterprise Office|
|5||The Contracts and Sponsorship Manager|
|6||Representative of the Research & Development office of the York teaching hopsital NHS Foundation Trust|
|7-12||Members of University of York or NEY NHS Alliance staff who are engaged in, or who have experience of, clinical trials|
|1||Professor Karl Atkin||Chair|
|2||Vacant||HYMS, Director of Research|
|3||Professor David Torgerson||Health Sciences|
|4||Jennifer Gilmartin (Acting)||Research & Enterprise|
|5||Dr Michael Barber||Research & Enterprise|
|6||Dr Deborah Philips||York Teaching Hospitals NHS Foundation Trust|
|7||Professor Charles Lacey||HYMS|
|8||Professor Paul Kaye||HYMS|
|9||Sarah Cockayne||Health Sciences|
|10||Professor Eve Roman||Health Sciences|
Additional documents and information are available to members of the research committee.